Crispr Therapeutics Ag (CRSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 563 | 1,088 | 1,358 | 32,325 | 2,387 |
| Gross Profit | 563 | 1,088 | 1,358 | 32,325 | 2,387 |
| Operating Expenses | 49,995 | 38,374 | 28,355 | 31,353 | 25,957 |
| Operating Income | -49,432 | -37,286 | -26,997 | 972 | -23,570 |
| Other Income | -1,142 | -998 | -1,217 | -412 | -430 |
| Pre-tax Income | -50,574 | -38,284 | -28,214 | 560 | -24,000 |
| Income Tax | 137 | 96 | 86 | 420 | 707 |
| Net Income Continuous | -50,711 | -38,380 | -28,300 | 140 | -24,707 |
| Net Income | $-50,711 | $-38,380 | $-28,300 | $140 | $-24,707 |
| EPS Basic Total Ops | -1.07 | -0.82 | -0.62 | 0.01 | -0.62 |
| EPS Basic Continuous Ops | -1.07 | -0.82 | -0.62 | 0.01 | -0.62 |
| EPS Diluted Total Ops | -1.07 | -0.82 | -0.62 | 0.01 | -0.62 |
| EPS Diluted Continuous Ops | -1.07 | -0.82 | -0.62 | 0.01 | -0.62 |
| EBITDA(a) | $-48,549 | $-36,421 | $-26,171 | $1,778 | $-22,778 |